Macy's: The Beat the Market Refused to Believe

Macy's reported an earnings "beat" on the morning of September 10, and the stock went down. Adjusted earnings of $0.63 a share came in far above the roughly $0.35 to $0.37 analysts expected, and sales of $4.9 billion topped the consensus by more than a hundred million — yet shares fell about 4% premarket and kept sliding into the next session, dropping to around $20.50, down nearly 14% over the prior month. Investors did not ignore the number; they disbelieved it. Figuring out which reading is right decides whether this selloff is a chance to buy a cheap turnaround at a discount or a fair price for a retailer that is still shrinking.

The beat was written by the tariff refund

The reason the stock fell after a headline blowout is that most of the beat was a one-time bookkeeping credit, not underlying demand. A net tariff-refund benefit worth about $0.23 a share sat inside that $0.63 figure — roughly a third of the quarter's adjusted earnings. Strip it out and adjusted EPS was about $0.40, up a respectable 14% from the prior-year quarter's $0.35, but nowhere near the headline gap. The same accounting shows up on the margin line: gross margin expanded 180 basis points to 41.5% of sales, and management said essentially all of that expansion came from the refunds, leaving the operating margin roughly flat underneath.

The refunds themselves were real money — Macy's received about $116 million in IEEPA tariff repayments — and it chose to keep only about $20 million (worth roughly $0.05 a share) for the bottom line, reinvesting the rest into remodels, marketing, and pricing. So the cash was genuine, but it is not repeatable, and it flatters the quarter's economics in a way the market can see through immediately.

The guidance is where the skepticism is grounded

Shares kept falling because the company's forward view, not the beat, is what sets the next phase — and that view underwhelmed. Macy's raised its full-year adjusted EPS range to $2.15 to $2.35 from a prior $2.00 to $2.10, but that revised midpoint essentially matches, rather than clears, what Wall Street already expected. More telling, the sales guidance of roughly $21.7 billion to $21.8 billion for the fiscal year ending early next year came in below consensus, and the third quarter stacks up as the weakest compare: Macy's guided Q3 comparable sales to something between a loss and barely positive, and adjusted EPS to a loss of roughly $0.19 to $0.23, because it is lapping a 3.2% comp gain from a year ago.

That is the honest version of this quarter: a refund-inflated beat sitting in front of a back half that gets harder, not easier.

What the market is nonetheless underpricing

Step back from the accounting, though, and the operating evidence underneath is more constructive than a 20-day slide suggests — and it is what separates the good company question from the good stock question here. Comparable sales rose 2.7% across all nameplates, the fifth consecutive quarter of growth, which is not what a terminal business produces. The growth is also concentrated where it is most durable: Bloomingdale's comps jumped 11.3%, its second straight quarter of double-digit growth and its highest Q2 sales volume in the brand's 154-year history, while Bluemercury rose 6.2%. The flagship Macy's banner managed only 1.1%, modest, but it benefits from the "Reimagine 200" remodel program, whose stores now make up about 60% of the go-forward fleet and 75% of its sales, and management says every cohort of remodeled stores is growing.

The earnings quality concerns itself persist, but the headline numbers behind them have turned decisively positive. Free cash flow swung from an $88 million outflow in the first half of last year to a $262 million inflow this year, on roughly $1.3 billion of cash on hand and modest net debt of about $1.1 billion. The company returned $201 million to shareholders in the first half via dividends and buybacks, with about $1 billion still left on the repurchase authorization.

That cash generation matters because it is what makes the valuation defendable. At around $20.50, Macy's trades at roughly seven times trailing earnings, about three times EV/EBITDA, and under a quarter of sales — with a dividend yield near 3.7% that has been paid for about 22 consecutive years and is covered several times over by free cash flow. The stock closed inside its 52-week range of about $16.41 to $26.59, so it has already given back most of its 2026 rebound.

The test that decides the next year

The honest framing is that the market is correct to discount a beat written by a tariff refund — that is not a reason to pay up. But it is not obviously correct that the discount should extend to roughly seven times earnings when the underlying, ex-refund business just grew adjusted EPS 14% on a fifth straight quarter of comp growth, with Bloomingdale's compounding in double digits and free cash flow inflecting positive. That combination puts the bear argument on the specific failures of the next two quarters rather than on a permanent structural decline.

The falsifiable test is the holiday back half: whether Macy's can hold positive comparable sales and grow earnings without the refund cushion, through a Q3 that management itself has guided to a loss and a tough year-ago compare. If comps stall and the ex-refund EPS growth evaporates, the discount is earned and this is a value trap at any multiple. If the remodeled stores keep compounding and EPS growth survives without the credit, then a company compounding mid-teens EPS with a covered 3.7% yield at seven times earnings is cheap on the evidence, not just cheap on hope.

The next report — the holiday quarter after the season — is the proof point. Until then, the selloff is as much a statement about refund accounting as it is about the business, and the two should not be mistaken for each other.